Risk factors: CD8+:FOXP3+ cell ratio is a novel survival marker for colorectal cancer

Nature Reviews Clinical Oncology

Volumn 7, Issue 6, 2010, Pages 299-

  Kirk, Rebecca ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; TRANSCRIPTION FACTOR FOXP3;

ARTICLE; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CD8+ T LYMPHOCYTE; COLORECTAL CANCER; CORRELATION ANALYSIS; HUMAN; PRIORITY JOURNAL; RISK FACTOR; TUMOR CELL; TUMOR IMMUNITY; CELL STRUCTURE; CELLS; COLORECTAL TUMOR; FEMALE; IMMUNOLOGY; MALE; MIDDLE AGED; MORTALITY;

BIOLOGICAL MARKERS; CELLS; CELLULAR STRUCTURES; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 77953171013     PISSN: 17594774     EISSN: 17594782     Source Type: Journal    
DOI: 10.1038/nrclinonc.2010.79     Document Type: Article

References (1)

1. Suzuki, H. et al. Intratumoral CD8+ T/ FOXP3+ cell ratio is a predictive marker for survival in patients with colorectal cancer. Cancer Immunol. Immunother. 59, 653-661 (2010)